Imagine printing a plastic part that can move or change its electrical properties on command, like a remote-controlled muscle. Instead of just printing a shape, this tech lets you align tiny magnetic particles inside the material while it's being built. It's like baking a cake where you can precisely place every chocolate chip to create a hidden circuit or a specific movement pattern.
Current 3D printing cannot control the internal orientation of functional particles, meaning printed composites are passive and cannot be 'programmed' to react to external stimuli.
Developed optimized core-shell nanoparticles and a functional ink for 3D printing active composites, validated through in-vitro cell viability tests.
If you are a regenerative medicine lab dealing with slow stem cell growth — this project developed 3D printed scaffolds that can be wirelessly actuated to stimulate growth and differentiation of stem cells.
If you are a water treatment facility dealing with persistent micropollutants — this project developed high-efficiency catalytic membranes that can be programmed to free wastewaters from these pollutants.
If you are a soft robotics manufacturer dealing with rigid, non-responsive components — this project developed a way to program mechanical and magnetic anisotropy to create next-generation actuatable systems.
Based on available project data, the technology is designed to be an affordable table-top solution for engineers and industrialists.
The project involves 4 industrial partners, including multinational corporations like Siemens, to advise on the transferability and exploitability of the technology.
Based on available project data, specific licensing terms are not mentioned, but the project is currently in the research and development phase under a HORIZON-EIC grant.
It fills a gap that existing technologies like selective laser sintering or stereolithography cannot, by allowing precise control over the orientation of functional particles during printing.
The project period runs from 2022-10-01 to 2026-09-30, suggesting the technology is still being developed and validated.
The consortium is well-balanced for technology transfer, featuring a 44% industry ratio with 4 SMEs and 4 universities across 5 countries. The inclusion of a multinational corporation (Siemens) and specialized SMEs (Nanoscribe, Transpharmation) ensures that the research is aligned with commercial feasibility and industrial needs from the start.
Contact the Universitat de Barcelona regarding the EVA project
Contact us to explore licensing opportunities for magnetoelectric 3D printing
